In the past five years numerous reports have suggested that ganglion cell function can be tested by means of a specialized form of electroretinography, the so-called pattern electroretinogram (PERG). Because of the important potentials of a ganglion cell test for clinical use this technique has been applied by several investigators to patients with (presumed) ganglion cell dysfunction, especially glaucoma. On grounds of principle we had reason to question whether the reported positive results should be attributed to ganglion cell dysfunction or to other factors such as optical disturbances. We investigated in this study the PERG as a function of visual field loss in glaucoma patients with careful control of optical factors. We did not find changes in PERG as a function of field loss. So either field loss is not related to the mass behaviour of ganglion cells, or ganglion cells are not the prime basis of the PERG. We believe the latter to be true.
The decision to use therapy in toxoplasma retinochorioiditis depends on the location of the active lesion and the presence of vitreous activity. In eyes with dense vitreous clouding it can be difficult to see whether the macular region is involved or not. In theory the localisation of a lesion can be estimated on the basis of the flash ERG. The standard flash electroretinogram was recorded in 23 patients with inactive toxoplasma retinochorioiditis lesions in the retina. In 17 cases a lesion was present within the central 12 degrees of the visual field, 8 of these had a reduced photopic ERG. In 15 patients lesions were found outside the central 12 degrees, in 8 of whom the scotopic ERG was reduced. We conclude that the ERG can be of use in indicating the scar location in patients with dense vitreous clouding.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.